A61K36/42

POLYSACCHARIDE-PEPTIDE COMPLEX FOR LOWERING BLOOD SUGAR, BLOOD LIPID AND GLYCOSYLATED HEMOGLOBIN LEVELS, AND PREPARATION METHOD
20220323554 · 2022-10-13 ·

Disclosed are a polysaccharide-peptide composite and a method of preparing the same. The polysaccharide-peptide composite is prepared from a bitter melon peptide (BMP) powder, gardenia fruit oil, a soybean polypeptide powder, an oat dietary fiber powder, a konjac powder, a corn silk, a mulberry leaf extract, a Poria cocos extract, a hawthorn extract, nutritional yeast and a pancreatin. The BMP powder is prepared by temperature-controlled hydrolysis, staged enzymatic hydrolysis and multiple filtrations. The gardenia fruit oil is prepared by staged enzymatic hydrolysis, multi-step centrifugation, filtration and stratification.

POLYSACCHARIDE-PEPTIDE COMPLEX FOR LOWERING BLOOD SUGAR, BLOOD LIPID AND GLYCOSYLATED HEMOGLOBIN LEVELS, AND PREPARATION METHOD
20220323554 · 2022-10-13 ·

Disclosed are a polysaccharide-peptide composite and a method of preparing the same. The polysaccharide-peptide composite is prepared from a bitter melon peptide (BMP) powder, gardenia fruit oil, a soybean polypeptide powder, an oat dietary fiber powder, a konjac powder, a corn silk, a mulberry leaf extract, a Poria cocos extract, a hawthorn extract, nutritional yeast and a pancreatin. The BMP powder is prepared by temperature-controlled hydrolysis, staged enzymatic hydrolysis and multiple filtrations. The gardenia fruit oil is prepared by staged enzymatic hydrolysis, multi-step centrifugation, filtration and stratification.

COMPOSITIONS FOR PREVENTION OF SIDE EFFECTS RELATED TO ALCOHOL CONSUMPTION
20230112567 · 2023-04-13 ·

The present composition provides for mitigating adverse effects of alcohol consumption. The composition includes a fructose source comprising between 5% and 75% of a total weight of the composition, a niacinamide source comprising between 0.1% and 1% of the total weight, and a glycoprotein source comprising between 0.1% and 2% of the total weight, wherein the total weight is a weight prior to inclusion with a hydrating source. The composition can be disposed in a powder or dissolved form, as part of a concentrate, and/or part of a beverage. The composition can include mixability for diluting or mixing with the liquid or beverage for user consumption and absorprtion.

COMPOSITIONS FOR PREVENTION OF SIDE EFFECTS RELATED TO ALCOHOL CONSUMPTION
20230112567 · 2023-04-13 ·

The present composition provides for mitigating adverse effects of alcohol consumption. The composition includes a fructose source comprising between 5% and 75% of a total weight of the composition, a niacinamide source comprising between 0.1% and 1% of the total weight, and a glycoprotein source comprising between 0.1% and 2% of the total weight, wherein the total weight is a weight prior to inclusion with a hydrating source. The composition can be disposed in a powder or dissolved form, as part of a concentrate, and/or part of a beverage. The composition can include mixability for diluting or mixing with the liquid or beverage for user consumption and absorprtion.

METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING FIBROSIS RESULTING FROM A CORONAVIRUS INFECTION
20230107479 · 2023-04-06 ·

The invention provides methods, compositions, and kits using a galectin-3 inhibitor to prevent and treat fibrosis resulting from a coronavirus infection, such as fibrosis in a subject's lung resulting from a coronavirus 2 infection.

METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING FIBROSIS RESULTING FROM A CORONAVIRUS INFECTION
20230107479 · 2023-04-06 ·

The invention provides methods, compositions, and kits using a galectin-3 inhibitor to prevent and treat fibrosis resulting from a coronavirus infection, such as fibrosis in a subject's lung resulting from a coronavirus 2 infection.

METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING RETINAL DAMAGE IN GLAUCOMA

The invention provides methods, compositions, and kits using a galectin-3 inhibitor to prevent and treat retinal nerve damage in a subject suffering from glaucoma.

METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING RETINAL DAMAGE IN GLAUCOMA

The invention provides methods, compositions, and kits using a galectin-3 inhibitor to prevent and treat retinal nerve damage in a subject suffering from glaucoma.

HERBAL FORMULATION AND METHOD OF ADMINISTERING THE SAME
20230109311 · 2023-04-06 ·

The present disclosure relates to an herbal composition and a method of administering the composition including administering the composition in pill or capsule form on a routine basis and administering tadalafil on a routine basis in some instances for the purpose of increasing energy, alertness, clarity, memory, and sexual enhancement in individuals, and particularly in males.

HERBAL FORMULATION AND METHOD OF ADMINISTERING THE SAME
20230109311 · 2023-04-06 ·

The present disclosure relates to an herbal composition and a method of administering the composition including administering the composition in pill or capsule form on a routine basis and administering tadalafil on a routine basis in some instances for the purpose of increasing energy, alertness, clarity, memory, and sexual enhancement in individuals, and particularly in males.